PL1856537T3 - Sposób sprawdzania i kontroli procesu fermentacji kwasu mlekowego u ssaków/ścieżki metabolicznej tlenowej fermentacji glukozy w organizmie ssaczym - Google Patents

Sposób sprawdzania i kontroli procesu fermentacji kwasu mlekowego u ssaków/ścieżki metabolicznej tlenowej fermentacji glukozy w organizmie ssaczym

Info

Publication number: PL1856537T3
Authority: PL; Poland
Prior art keywords: mammalian; checking; controlling; metabolic pathway; agf
Prior art date: 2005-03-07

Application number

PL06723195T

Other languages

English (en)

Inventor

Johannes Coy

Original Assignee

Johannes Coy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-07

Filing date

2006-03-03

Publication date

2011-10-31

2005-03-07 Priority claimed from EP05004930A external-priority patent/EP1701165A1/en

2006-03-03 Application filed by Johannes Coy filed Critical Johannes Coy

2011-10-31 Publication of PL1856537T3 publication Critical patent/PL1856537T3/pl

Links

238000000034 method Methods 0.000 title abstract 4
230000004151 fermentation Effects 0.000 title abstract 3
238000000855 fermentation Methods 0.000 title abstract 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 2
239000008103 glucose Substances 0.000 title abstract 2
230000037353 metabolic pathway Effects 0.000 title abstract 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title 2
235000014655 lactic acid Nutrition 0.000 title 1
239000004310 lactic acid Substances 0.000 title 1
101000800498 Homo sapiens Transketolase-like protein 1 Proteins 0.000 abstract 2
102100033108 Transketolase-like protein 1 Human genes 0.000 abstract 2
239000012190 activator Substances 0.000 abstract 1
239000012472 biological sample Substances 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
General Engineering & Computer Science (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Hematology (AREA)
Obesity (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Dermatology (AREA)

PL06723195T 2005-03-07 2006-03-03 Sposób sprawdzania i kontroli procesu fermentacji kwasu mlekowego u ssaków/ścieżki metabolicznej tlenowej fermentacji glukozy w organizmie ssaczym PL1856537T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP05004930A EP1701165A1 (en)	2005-03-07	2005-03-07	Therapeutic and diagnostic uses of TKTL1 and inhibitors and activators thereof
EP05013170		2005-06-17
PCT/EP2006/001951 WO2006094716A1 (en)	2005-03-07	2006-03-03	Method for ckecking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism
EP06723195A EP1856537B1 (en)	2005-03-07	2006-03-03	Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism

Publications (1)

Publication Number	Publication Date
PL1856537T3 true PL1856537T3 (pl)	2011-10-31

Family

ID=36224891

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL10009323T PL2256500T3 (pl)	2005-03-07	2006-03-03	Zastosowanie inhibitorów enzymu TKTL1
PL06723195T PL1856537T3 (pl)	2005-03-07	2006-03-03	Sposób sprawdzania i kontroli procesu fermentacji kwasu mlekowego u ssaków/ścieżki metabolicznej tlenowej fermentacji glukozy w organizmie ssaczym

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL10009323T PL2256500T3 (pl)	2005-03-07	2006-03-03	Zastosowanie inhibitorów enzymu TKTL1

Country Status (11)

Country	Link
US (3)	US7754437B2 (pl)
EP (2)	EP2256500B1 (pl)
JP (1)	JP5095600B2 (pl)
AT (1)	ATE509279T1 (pl)
AU (1)	AU2006222277B2 (pl)
CA (1)	CA2600206C (pl)
DK (2)	DK1856537T3 (pl)
ES (1)	ES2480416T3 (pl)
PL (2)	PL2256500T3 (pl)
PT (1)	PT2256500E (pl)
WO (1)	WO2006094716A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102007013903A1 (de)	2007-03-20	2008-09-25	Coy, Johannes F., Dr.	Getränk
DE102010007243B4 (de) *	2010-02-09	2011-11-17	Frank Kischkel	Therapieoptimierung bei Krebspatienten durch Austesten von Therapiekombinationen mittels in vitro Testungen (Zusatz)
DE102011008016A1 (de) *	2011-01-06	2012-07-12	Johannes F. Coy	Schokoladenmasse
DE102020116980A1 (de) *	2020-06-27	2021-12-30	TAVARGENIX GmbH	Verwendung von Co-Enzym-Antagonisten zur Stoffwechselverlangsamung
CN112730734A (zh) *	2020-12-22	2021-04-30	河南星汉生物科技有限公司	一种葡萄糖发酵乳酸中发酵液残糖的检验方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4006219A (en) *	1972-08-10	1977-02-01	Ceres Pharmacal Company	Composition and method for countering effects of alcohol consumption
DE2834706A1 (de) *	1978-08-08	1980-02-14	Boehringer Mannheim Gmbh	Verfahren und reagens zur bestimmung von glutamat-oxalacetat-transaminase und glutamat-pyruvat-transaminase
US4594237A (en) *	1984-04-16	1986-06-10	Walter Ziegler	Method for testing chemical and biological substances
US6919185B2 (en) *	2000-05-31	2005-07-19	Bayer Aktiengesellschaft	Regulation of human transketolase-like enzyme
US7381713B2 (en) *	2000-12-04	2008-06-03	Sioan-Kettering Institute For Cancer Research	Treatment of cancer by reduction of intracellular energy and pyrimidines
EP1354961B1 (en)	2002-04-19	2008-01-23	Johannes Dr. Coy	Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene

2006
- 2006-03-03 PL PL10009323T patent/PL2256500T3/pl unknown
- 2006-03-03 ES ES10009323.6T patent/ES2480416T3/es not_active Expired - Lifetime
- 2006-03-03 PT PT100093236T patent/PT2256500E/pt unknown
- 2006-03-03 US US11/571,205 patent/US7754437B2/en not_active Expired - Lifetime
- 2006-03-03 EP EP10009323.6A patent/EP2256500B1/en not_active Expired - Lifetime
- 2006-03-03 AT AT06723195T patent/ATE509279T1/de active
- 2006-03-03 EP EP06723195A patent/EP1856537B1/en not_active Expired - Lifetime
- 2006-03-03 JP JP2008500098A patent/JP5095600B2/ja not_active Expired - Lifetime
- 2006-03-03 AU AU2006222277A patent/AU2006222277B2/en not_active Expired
- 2006-03-03 WO PCT/EP2006/001951 patent/WO2006094716A1/en not_active Ceased
- 2006-03-03 CA CA2600206A patent/CA2600206C/en not_active Expired - Lifetime
- 2006-03-03 DK DK06723195.1T patent/DK1856537T3/da active
- 2006-03-03 DK DK10009323.6T patent/DK2256500T3/da active
- 2006-03-03 PL PL06723195T patent/PL1856537T3/pl unknown
2010
- 2010-05-28 US US12/790,257 patent/US11236381B2/en active Active
2020
- 2020-01-29 US US16/775,454 patent/US11359225B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2600206A1 (en)	2006-09-14
PT2256500E (pt)	2014-07-18
JP2008531065A (ja)	2008-08-14
DK2256500T3 (da)	2014-07-14
AU2006222277B2 (en)	2011-04-07
CA2600206C (en)	2011-01-04
US7754437B2 (en)	2010-07-13
PL2256500T3 (pl)	2014-10-31
DK1856537T3 (da)	2011-07-18
ATE509279T1 (de)	2011-05-15
US20080095703A1 (en)	2008-04-24
EP1856537A1 (en)	2007-11-21
US20100240687A1 (en)	2010-09-23
US11236381B2 (en)	2022-02-01
AU2006222277A1 (en)	2006-09-14
US11359225B2 (en)	2022-06-14
EP2256500A2 (en)	2010-12-01
ES2480416T3 (es)	2014-07-28
JP5095600B2 (ja)	2012-12-12
EP2256500B1 (en)	2014-04-23
US20200248227A1 (en)	2020-08-06
WO2006094716A1 (en)	2006-09-14
EP1856537B1 (en)	2011-05-11
EP2256500A3 (en)	2012-08-29

Publication	Publication Date	Title
Armiger et al.	1986	The interpretation of on-line process measurements of intracellular NADH in fermentation processes
Rajan et al.	2017	Monitoring pH, temperature and humidity in long-term stem cell culture in CO 2 incubator
CN103698541B (zh)	2015-12-09	谷氨酸发酵在线检测系统及采用该系统在线检测的方法
Dietzsch et al.	2013	On-line multiple component analysis for efficient quantitative bioprocess development
CN102131914A (zh)	2011-07-20	用于对血浆进行细菌学测试的装置和方法
WO2018052834A1 (en)	2018-03-22	Self regulating bioreactor apparatus and methods
JP2023106453A (ja)	2023-08-01	酵素組成物を用いたクレアチンレベルの検出
PL2256500T3 (pl)	2014-10-31	Zastosowanie inhibitorów enzymu TKTL1
CN103528915A (zh)	2014-01-22	智能型压感式bod测定仪
EP3458816B1 (en)	2021-07-28	Gas measurement method and device for batch fermentation and in-vitro analysis platforms
CN104990913A (zh)	2015-10-21	一种基于金纳米颗粒生长检测葡萄糖的方法
CN201935910U (zh)	2011-08-17	一种检测水质毒性的装置
Rolfe	2006	Sensing in tissue bioreactors
Lamboursain et al.	2002	A lab‐built respirometer for plant and animal cell culture
Reddy et al.	1971	Studies on stress-susceptibility: the relationship between serum enzyme changes and the degree of stress-susceptibility
Håkanson et al.	1991	General sampling system for sterile monitoring of biological processes
EP4444849A1 (en)	2024-10-16	Method and apparatus for sterile and noninvasive measurements of substances in bioreactors and other sterile environments
Roda et al.	1991	Microdialysis and luminescent probe: analytical and clinical aspects
Zhao et al.	2026	In vivo real-time monitoring of tissue perfusion via L-lactate levels in interstitial fluid: an innovative and portable microfluidic device trial using a pig model
CN110872607A (zh)	2020-03-10	一种检测碱性磷酸酶的荧光生物传感器及其制备方法
Rahmatnejad	2023	Noninvasive Process Monitoring for Cell Therapy Applications
Karube	1988	[11] Hybrid biosensors for clinical analysis and fermentation control
Schmidt et al.	2008	Monitoring ATP status in the metabolism of production cell lines
US20230008576A1 (en)	2023-01-12	A host-microbe co-culture perfusion bioreactor for discovery of secreted products and novel interactions at the human-microbiota interface
Ye et al.	2006	Ex-Vivo Expansion and Differentiation of Haematopoietic Stem Cells (Hscs) Using on-Line Monitoring and Design of Experiments (DOE)